Navigation Links
March of Dimes establishes 2 new perinatal bioethics awards
Date:10/23/2009

WASHINGTON, D.C., OCTOBER, 2009 A bioethicist who specializes in moral dilemmas families face when making medical decisions for critically-ill newborns was honored with the first-ever March of Dimes Distinguished Lectureship in Perinatal Bioethics.

John D. Lantos, MD, a nationally-recognized pediatrician and ethicist, delivered his lecture "Doctors are All Alike, Parents are All Different" at the American Society of Bioethics and Humanities' 11th annual meeting here Oct. 16. Dr. Lantos directs the Children's Mercy Bioethics Center at Children's Mercy Hospital, and holds the John B. Francis Chair in Bioethics at the Center for Practical Bioethics in Kansas City.

"Dr. Lantos has a deep appreciation for the choices doctors and parents face," said Alan R. Fleischman, MD, March of Dimes medical director. "He draws on his understanding of medicine and ethics as he explores the moral predicaments faced in neonatal intensive care units."

The March of Dimes established the two new awards the Distinguished Lectureship in Perinatal Bioethics and the Young Scholar Award in Perinatal Bioethics to honor the work of established scholars in perinatal ethics and to encourage young researchers to enter the field. Perinatal ethics address a broad range of moral issues that arise before, during and after pregnancy, such as deciding whether to use new reproductive technologies, to undergo genetic and diagnostic testing, or to pursue aggressive treatment when a baby's born sick or too soon, all of which involve the potential for benefit and the possibility of risk.

"Parents of critically ill babies face decisions that most of us cannot even imagine. They need information to make those decisions. They also need doctors to understand what they are going through," said Dr. Lantos.

"These two new awards from the March of Dimes will stimulate research in this crucial and complex area of pediatrics and bioethics. I'm proud to be chosen as the award's first recipient."

Dr. Lantos has published more than 150 peer-reviewed articles, as well as books on medical ethics and neonatal care, including "Neonatal Bioethics; The Last Physician: Walker Percy and the Moral Life of Medicine; Do We Still Need Doctors?"; and "The Lazarus Case: Life and Death Issues in Neonatal Intensive Care", which explores the moral dilemma experienced in the NICU. His recent research focuses on the medical and social causes of rising preterm birth.

Dr. Lantos is visiting professor in pediatrics at the University of Chicago and past president of the American Society of Bioethics and Humanities and American Society of Law, Medicine and Ethics. He was the first named to the John B. Francis Chair in Bioethics. Francis was a philanthropist who developed life-sustaining respiratory technology.

Also, the March of Dimes presented Sarah Clark Miller, Ph.D., assistant professor of Philosophy at the University of Memphis, Tennessee, the March of Dimes first-ever Young Scholar Award in Perinatal Bioethics for her paper entitled: "Visual Intimacies: Ultrasound, Reproductive Autonomy, and the Pregnancy Relationship."

"As a woman who went into preterm labor at 25 weeks and who now has avery healthy son, it is especially meaningful to receive an award sponsored by the March of Dimes, an organization that provided excellent information throughout my pregnancy," said Dr. Miller, whose work focuses on ethics, the history of moral philosophy, bioethics, feminist theory, and social and political philosophy.

Both awards are expected to be presented annually. Distinguished Lectureship recipients will receive a $3,000 prize, while the Young Scholars will receive $1,000.


'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert

Related biology news :

1. Media highlights in the March 1 issue of Biophysical Journal
2. March GEOLOGY and GSA TODAY media highlights
3. Story tips from the Department of Energys Oak Ridge National Laboratory, March 2008
4. AGU Journal Highlights -- March 19, 2008
5. K-State contributions to red flour beetle genome sequencing featured in March 27 issue of Nature
6. American Chemical Societys Weekly PressPac -- March 19, 2008
7. American Chemical Societys Weekly PressPac -- March 26, 2008
8. March of Dimes announces Prematurity Campaign expansion at Surgeon Generals conference
9. Far-reaching genetics topics to be addressed: 2009 Annual Clinical Genetics Meeting, March 25-29
10. March launch planned for ESAs gravity mission
11. March of Dimes provides $2.7 million in new funding for preterm birth research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... 2017 Summary This report provides all ... partnering interests and activities since 2010. ... Read the full report: ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... 23, 2017 Kineta, Inc., a biotechnology ... therapies in immuno-oncology, today announced the discovery and ... compounds that activate interferon response factor 3 (IRF3) ... immune-mediated tumor regression in a murine colon carcinoma ... demonstrated complete tumor regression to initial drug treatment ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... announced the hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global ... and joint development activities. , “Dr. Floyd’s career has spanned 30 years in ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
Breaking Biology Technology: